Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing.
Business Model:
Revenue: $14.5M
Employees: 2-10
Address: 500 Park Ave
City: New York
State: NY
Zip: 10022
Country: US
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing. Our team has insight on what drives success from assessing management and clinical development plans for over 25 years.
Contact Phone:
+12128911100
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2020 | JenaValve Technology | Series D | 0 |
5/2020 | CalciMedica | Series C | 15M |
2/2015 | Invuity | Equity | 22.9M |
3/2021 | CalciMedica | Series D | 0 |
1/2012 | Invuity | Venture Round | 2M |
2/2020 | JenaValve Technology | Venture Round | 50M |
6/2012 | Invuity | Series D | 25M |
4/2013 | Celator Pharmaceuticals | Private Equity Round | 39.3M |
3/2014 | Invuity | Series E | 36M |
3/2021 | CalciMedica | Series D | 0 |
5/2020 | CalciMedica | Series C | 0 |
2/2020 | JenaValve Technology | Series D | 0 |
2/2015 | Invuity | Private Equity Round | 0 |
3/2014 | Invuity | Series E | 0 |
4/2013 | Celator Pharmaceuticals | Private Equity Round | 0 |
6/2012 | Invuity | Series D | 0 |
1/2012 | Invuity | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|